Efficacy of Glycopyrronium added to Budesonide/Formoterol in patients with Asthma-COPD overlap syndrome
Not Applicable
- Conditions
- patients with Asthma-COPD overlap syndrom
- Registration Number
- JPRN-UMIN000026651
- Lead Sponsor
- Toyama City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with unstable asthma COPD overlap syndrome
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of respiratory functions (FEV1, FVC) after 4 week treatment
- Secondary Outcome Measures
Name Time Method Improvement of respiratory symptoms after 4 week treatment